Quarterly report · Q2
4360.TEDINET S100S268
Period2023-04-01 → 2023-09-30
Filed2023-11-13
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥4.8bn | 2023-04-01 → 2023-09-30 | Cons. | Net sales |
| Revenue | ¥11.9bn | 2022-04-01 → 2023-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥5.1bn | 2022-04-01 → 2022-09-30 | Cons. | Net sales |
| Operating income | −¥12m | 2023-04-01 → 2023-09-30 | Cons. | Operating income |
| Operating income | ¥322m | 2022-04-01 → 2022-09-30 | Cons. | Operating income |
| Ordinary income | ¥35m | 2023-04-01 → 2023-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥1.2bn | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥474m | 2022-04-01 → 2022-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥83m | 2023-04-01 → 2023-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥520m | 2022-04-01 → 2022-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥61m | 2023-04-01 → 2023-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥821m | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥383m | 2022-04-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥62m | 2023-04-01 → 2023-09-30 | Cons. | Profit loss |
| Net income | ¥383m | 2022-04-01 → 2022-09-30 | Cons. | Profit loss |
| Total assets | ¥14.6bn | at 2023-09-30 | Cons. | Assets |
| Total assets | ¥15.0bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥14.2bn | at 2022-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥3.4bn | at 2023-09-30 | Cons. | Liabilities |
| Total liabilities | ¥4.0bn | at 2023-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥11.2bn | at 2023-09-30 | Cons. | Net assets |
| Net assets / equity | ¥11.0bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥10.6bn | at 2022-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥3.5bn | at 2023-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥3.7bn | at 2023-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥3.5bn | at 2023-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥3.7bn | at 2023-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.6bn | at 2022-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.0bn | at 2022-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | −¥61m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.6bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥372m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥210m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | ¥199m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | ¥300m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥27m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥125m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥51m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥7.7 | 2023-04-01 → 2023-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-6.8 | 2023-07-01 → 2023-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥103.26 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥48.32 | 2022-04-01 → 2022-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥33.3 | 2022-07-01 → 2022-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 76.9% | at 2023-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 73.5% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 74.5% | at 2022-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 24
| Segment | Item | Period | Value |
|---|---|---|---|
| jpcrp040300-q2r_E36769-000Fine Chemical Businessreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥1.7bn |
| jpcrp040300-q2r_E36769-000Fine Chemical Businessreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥1.7bn |
| jpcrp040300-q2r_E36769-000Fine Chemical Businessreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥254m |
| jpcrp040300-q2r_E36769-000Flame Retardants Businessreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥2.4bn |
| jpcrp040300-q2r_E36769-000Flame Retardants Businessreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥2.4bn |
| jpcrp040300-q2r_E36769-000Flame Retardants Businessreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥270m |
| jpcrp040300-q2r_E36769-000Health Support Businessreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥714m |
| jpcrp040300-q2r_E36769-000Health Support Businessreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥714m |
| jpcrp040300-q2r_E36769-000Health Support Businessreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥33m |
| —segment total | revenue | 2023-04-01 → 2023-09-30 | ¥4.8bn |
| —segment total | revenue external | 2023-04-01 → 2023-09-30 | ¥4.8bn |
| —segment total | segment profit | 2023-04-01 → 2023-09-30 | ¥558m |
| jpcrp040300-q2r_E36769-000Fine Chemical Businessreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥1.7bn |
| jpcrp040300-q2r_E36769-000Fine Chemical Businessreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥1.7bn |
| jpcrp040300-q2r_E36769-000Fine Chemical Businessreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥126m |
| jpcrp040300-q2r_E36769-000Flame Retardants Businessreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥2.8bn |
| jpcrp040300-q2r_E36769-000Flame Retardants Businessreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥2.8bn |
| jpcrp040300-q2r_E36769-000Flame Retardants Businessreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥665m |
| jpcrp040300-q2r_E36769-000Health Support Businessreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥605m |
| jpcrp040300-q2r_E36769-000Health Support Businessreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥605m |
| jpcrp040300-q2r_E36769-000Health Support Businessreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥16m |
| —segment total | revenue | 2022-04-01 → 2022-09-30 | ¥5.1bn |
| —segment total | revenue external | 2022-04-01 → 2022-09-30 | ¥5.1bn |
| —segment total | segment profit | 2022-04-01 → 2022-09-30 | ¥808m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 467
| Item | Context | Value | Unit |
|---|---|---|---|
| Noncurrent liabilities | Prior1YearInstant | 80000000 | JPY |
| Noncurrent liabilities | CurrentQuarterInstant | 117000000 | JPY |
| Liabilities | Prior1YearInstant | 3972000000 | JPY |
| Liabilities | CurrentQuarterInstant | 3362000000 | JPY |
| Capital stock | Prior1YearInstant | 300000000 | JPY |
| Capital stock | CurrentQuarterInstant | 300000000 | JPY |
| Capital surplus | Prior1YearInstant | 3459000000 | JPY |
| Capital surplus | CurrentQuarterInstant | 3460000000 | JPY |
| Retained earnings | Prior1YearInstant | 7566000000 | JPY |
| Retained earnings | CurrentQuarterInstant | 7568000000 | JPY |
| Treasury stock | Prior1YearInstant | -474000000 | JPY |
| Treasury stock | CurrentQuarterInstant | -426000000 | JPY |
| Shareholders equity | Prior1YearInstant | 10852000000 | JPY |
| Shareholders equity | CurrentQuarterInstant | 10902000000 | JPY |
| Valuation difference on available for sale securities | Prior1YearInstant | 180000000 | JPY |
| Valuation difference on available for sale securities | CurrentQuarterInstant | 292000000 | JPY |
| Deferred gains or losses on hedges | Prior1YearInstant | 0 | JPY |
| Deferred gains or losses on hedges | CurrentQuarterInstant | -0 | JPY |
| Foreign currency translation adjustment | Prior1YearInstant | 6000000 | JPY |
| Foreign currency translation adjustment | CurrentQuarterInstant | 13000000 | JPY |
| Valuation and translation adjustments | Prior1YearInstant | 187000000 | JPY |
| Valuation and translation adjustments | CurrentQuarterInstant | 304000000 | JPY |
| Non controlling interests | Prior1YearInstant | - | JPY |
| Non controlling interests | CurrentQuarterInstant | 6000000 | JPY |
| Net assets | Prior1YearInstant | 11039000000 | JPY |
| Net assets | CurrentQuarterInstant | 11213000000 | JPY |
| Liabilities and net assets | Prior1YearInstant | 15012000000 | JPY |
| Liabilities and net assets | CurrentQuarterInstant | 14576000000 | JPY |
| Net sales | Prior1YTDDuration | 5104000000 | JPY |
| Net sales | CurrentYTDDuration | 4840000000 | JPY |
| Cost of sales | Prior1YTDDuration | 3898000000 | JPY |
| Cost of sales | CurrentYTDDuration | 3881000000 | JPY |
| Gross profit | Prior1YTDDuration | 1206000000 | JPY |
| Gross profit | CurrentYTDDuration | 958000000 | JPY |
| Selling general and administrative expenses | Prior1YTDDuration | 883000000 | JPY |
| Selling general and administrative expenses | CurrentYTDDuration | 970000000 | JPY |
| Operating income | Prior1YTDDuration | 322000000 | JPY |
| Operating income | CurrentYTDDuration | -12000000 | JPY |
| Interest and dividends income noi | Prior1YTDDuration | 22000000 | JPY |
| Interest and dividends income noi | CurrentYTDDuration | 20000000 | JPY |
| Foreign exchange gains noi | Prior1YTDDuration | 18000000 | JPY |
| Foreign exchange gains noi | CurrentYTDDuration | 4000000 | JPY |
| Subsidy income noi bounty | Prior1YTDDuration | 56000000 | JPY |
| Subsidy income noi bounty | CurrentYTDDuration | 0 | JPY |
| Insurance premiums refunded cancellation noi | Prior1YTDDuration | 32000000 | JPY |
| Insurance premiums refunded cancellation noi | CurrentYTDDuration | 14000000 | JPY |
| Other noi | Prior1YTDDuration | 22000000 | JPY |
| Other noi | CurrentYTDDuration | 11000000 | JPY |
| Non operating income | Prior1YTDDuration | 153000000 | JPY |
| Non operating income | CurrentYTDDuration | 51000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |